Minerva Neurosciences up More Than 100% This Week, but Is It a Better Pick Than Vertex Pharma?
Published on August 25, 2022
Minerva Neurosciences (NERV) and Vertex Pharmaceuticals (VRTX) are expected to benefit from the rising number of chronic diseases and continued technological advancements in the industry. Since NERV has gained more...